Biotech Blog Archives: September 2003
next page ·
30 September 2003
Genentech’s CEO on Big Pharma’s Issues
Genentech’s CEO on Big Pharma’s Issues
Arthur Levinson tackles drug pricing, patent disputes, consumer marketing, and stem-cell research
continue reading... » 0 Comments
30 September 2003
FDA’s McClellan Calls for More Sharing of Drug R&D Costs
FDA’s McClellan Calls for More Sharing of Drug R&D Costs
The U.S. is bearing a disproportionate share of drug research and development costs for medicines used globally, FDA commissioner Mark McClellan said Thursday.
He called for more equitable cost sharing and price setting. ‘If we do not find better ways to share the burden of developing new [...]
continue reading... » 0 Comments
29 September 2003
Drug Development, Genentech Style
Drug Development, Genentech Style
“Its promising colon cancer fighter Avastin is a prime example of how the biotech ‘keeps following the science’”
continue reading... » 0 Comments
29 September 2003
BIOTECH THAWS OUT
BIOTECH THAWS OUT:
“Small drug discovery firms are capitalizing on the positive momentum that’s returned to the market for biotechnology stocks. A dozen have announced plans this quarter to launch initial public stock offerings (IPOs), while nearly as many more hope to raise money through follow-on bids. The upturn, if it persists, may help rescue a [...]
continue reading... » 0 Comments
25 September 2003
Suit targets 13 generic drug makers
Suit targets 13 generic drug makers
“Jumping into the escalating legal battle against pharmaceutical manufacturers, Attorney General Thomas F. Reilly planned to file a lawsuit today against 13 generic drug makers, claiming they overcharged the state Medicaid program $50 million for more than 150 medications.”
continue reading... » 0 Comments
25 September 2003
Judge Allows Antitrust Case Against Seed Producers
Judge Allows Antitrust Case Against Seed Producers
“A federal judge on Friday let proceed an antitrust case that accused the Monsanto Company and other big agricultural seed giants of conspiring to control the world’s market in genetically modified crops.”
